Related Experiment Video
Updated: Jul 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Effect on hematologic risk factors for coronary heart disease of a cholesterol reducing diet
D J A Jenkins1, C W C Kendall, T H Nguyen
1Division of Endocrinology and Metabolism, Clinical Nutrition & Risk Factor Modification Center, St Michael's Hospital, Toronto, Ontario, Canada.
Insights
A cholesterol-lowering diet significantly reduced hematocrit and neutrophils, potentially lowering coronary heart disease (CHD) risk. These findings suggest cardiovascular benefits beyond lipid reduction.
Area of Science:
- Cardiovascular Health
- Hematology
- Nutritional Science
Background:
- Dietary portfolio interventions effectively lower serum cholesterol.
- The impact of such diets on hematologic risk factors for coronary heart disease (CHD) remains unclear.
- Reductions in hematocrit and neutrophils are associated with improved cardiovascular risk.
Purpose of the Study:
- To assess changes in hematological indices linked to cardiovascular health.
- To evaluate the effects of a cholesterol-lowering dietary portfolio over 1 year.
Main Methods:
- 66 hyperlipidemic subjects consumed a diet rich in plant sterols, soy protein, viscous fibers, and almonds for 12 months.
- 55 subjects completed the 1-year study, providing data for analysis.
Main Results:
- Significant reductions observed in hemoglobin, hematocrit, red blood cell count, and neutrophils.
- A significant increase in mean platelet volume was noted.
- Increased red cell osmotic fragility did not reach statistical significance.
Conclusions:
- The observed hematological changes align with a reduced risk of CHD.
- Further research is necessary to confirm if these hematological shifts contribute to cardiovascular benefits beyond lipid and blood pressure improvements.
Background:
A dietary portfolio of cholesterol-lowering ingredients has proved effective in reducing serum cholesterol. However, it is not known whether this dietary combination will also affect hematologic risk factors for coronary heart disease (CHD). Reductions in hematocrit and polymorphonuclear leukocytes have been reported to improve cardiovascular risk. We, therefore, report changes in hematological indices, which have been linked to cardiovascular health, in a 1-year assessment of subjects taking an effective dietary combination (portfolio) of cholesterol-lowering foods.
Methods:
For 12 months, 66 hyperlipidemic subjects were prescribed diets high in plant sterols (1.0 g/1000 kcal), soy protein (22.5 g/1000 kcal), viscous fibers (10 g/1000 kcal) and almonds (23 g/1000 kcal). Fifty-five subjects completed the study.
Results:
Over the 1 year, data on completers indicated small but significant reductions in hemoglobin (-1.5+/-0.6 g/l, P=0.013), hematocrit (-0.007+/-0.002 l/l, P<0.001), red cell number (-0.07+/-0.02 10(9)/l, P<0.001) and neutrophils (-0.34+/-0.13 10(9)/l, P=0.014). Mean platelet volume was also increased (0.16+/-0.07 fl, P=0.033). The increase in red cell osmotic fragility (0.05+/-0.03 g/l, P=0.107) did not reach significance.
Conclusions:
These small changes in hematological indices after a cholesterol-lowering diet are in the direction, which would be predicted to reduce CHD risk. Further research is needed to clarify whether the changes observed will contribute directly or indirectly to cardiovascular benefits beyond those expected from reductions previously seen in serum lipids and blood pressure.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Coronary Artery Disease I: Introduction
